Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Borenstein

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Infection and Immunity|June 1, 1983
Synovial fluid inhibits killing of Staphylococcus aureus by neutrophilsG L Simon, H G Miller, D G Borenstein
Spine|June 1, 1988
Evaluation and outcome of low-back pain of unknown etiologyS W Wiesel, H L Feffer, D G Borenstein
Arthritis and Rheumatism|May 1, 1987
Successful joint arthroplasty following Proteus morganii (Morganella morganii) septic arthritis: a four-year studyL M Katz, R J Lewis, D G Borenstein
Annals of the Rheumatic Diseases|August 1, 1983
Gas-liquid chromatographic analysis of synovial fluid: volatile short-chain fatty acids in septic arthritisD G Borenstein, C A Gibbs, R P Jacobs
American Journal of Hematology|October 1, 1995
Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulationP Chang, D L Aronson, D G Borenstein, et al.
The American Journal of Medicine|February 1, 1988
Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosusD E Moller, R E Ratner, D G Borenstein, et al.
Annals of Internal Medicine|November 1, 1978
The myocarditis of systemic lupus erythematosus: association with myositisD G Borenstein, W B Fye, F C Arnett, et al.
The American Journal of Medicine|September 1, 1993
Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisoneG E LaRochelle, A G LaRochelle, R E Ratner, et al.
Archives of Internal Medicine|December 1, 1986
Progressive systemic sclerosis and Graves' disease. Report of three casesD Nicholson, S White, A Lipson, et al.
The American Journal of Medicine|January 1, 1995
Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosusC M Neuwelt, S Lacks, B R Kaye, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Infection and Immunity|June 1, 1983
Synovial fluid inhibits killing of Staphylococcus aureus by neutrophilsG L Simon, H G Miller, D G Borenstein
Spine|June 1, 1988
Evaluation and outcome of low-back pain of unknown etiologyS W Wiesel, H L Feffer, D G Borenstein
Arthritis and Rheumatism|May 1, 1987
Successful joint arthroplasty following Proteus morganii (Morganella morganii) septic arthritis: a four-year studyL M Katz, R J Lewis, D G Borenstein
Annals of the Rheumatic Diseases|August 1, 1983
Gas-liquid chromatographic analysis of synovial fluid: volatile short-chain fatty acids in septic arthritisD G Borenstein, C A Gibbs, R P Jacobs
American Journal of Hematology|October 1, 1995
Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulationP Chang, D L Aronson, D G Borenstein, et al.
The American Journal of Medicine|February 1, 1988
Autoantibodies to the insulin receptor as a cause of autoimmune hypoglycemia in systemic lupus erythematosusD E Moller, R E Ratner, D G Borenstein, et al.
Annals of Internal Medicine|November 1, 1978
The myocarditis of systemic lupus erythematosus: association with myositisD G Borenstein, W B Fye, F C Arnett, et al.
The American Journal of Medicine|September 1, 1993
Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisoneG E LaRochelle, A G LaRochelle, R E Ratner, et al.
Archives of Internal Medicine|December 1, 1986
Progressive systemic sclerosis and Graves' disease. Report of three casesD Nicholson, S White, A Lipson, et al.
The American Journal of Medicine|January 1, 1995
Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosusC M Neuwelt, S Lacks, B R Kaye, et al.
Pageof 4